The Overlooked Realities of Women’s Bone and Joint Pain

For decades, women have been told that joint pain, frozen shoulder, fractures, and declining strength are simply the price of getting older. Something to endure and accept. This narrative has shaped expectations, clinical care, and how women interpret their own symptoms. Yet emerging science, highlighted in a recent 2-part conversation on the unPAUSED podcast with orthopedic surgeon Dr. Jocelyn Wittstein, reveals a troubling truth. This story is not only wrong. It is actively harming women.

Dr. Wittstein is an orthopedic surgeon, researcher, former collegiate athlete, and mother of five. Her work sits at the intersection of biomechanics, women’s health, and lived experience. From that vantage point, she has helped expose one of modern medicine’s most persistent blind spots: the failure to understand and address women’s musculoskeletal health during the menopausal transition.

That blind spot has left generations of women undiagnosed, under treated, and dismissed at precisely the time when their bodies are undergoing rapid and predictable biological change. As estrogen levels fluctuate and decline, bones, joints, muscles, and connective tissue are reshaped. Pain patterns shift and injury risk increases. Strength and stability can change in a matter of years, not decades. None of this is random, and none of it should be ignored.

This Is Not Just Aging, It Is Estrogen Withdrawal

Frozen shoulder, rapid bone loss, escalating joint pain, and a sudden rise in arthritis risk do not appear gradually or evenly across a woman’s lifespan. Instead, these conditions seem to coincide with the menopausall transition.

Women over 50 are significantly more likely than men to develop arthritis, and that disparity does not normalize until around age 80. Frozen shoulder overwhelmingly affects women between the ages of 40 and 60. Osteoporosis accelerates sharply during perimenopause, when estrogen levels fluctuate and then decline.

Labeling these changes as normal aging ignores basic biology. Estrogen is anti-inflammatory and protective. It supports bone remodeling, preserves cartilage, maintains muscle mass, and influences the integrity of connective tissue. When estrogen levels drop, pain thresholds change, injury risk changes, and the structural resilience of tissues changes as well.

These processes are not mysterious. They are measurable, predictable, and modifiable. When clinicians dismiss them as inevitable aging, women lose the opportunity for early intervention and effective prevention.

Frozen Shoulder Is a Menopause Related Condition Hiding in Plain Sight

Frozen shoulder has long been labeled idiopathic, a medical term that signals an unknown cause. That explanation has never fully made sense.

A condition that overwhelmingly affects women, occurs within a narrow age range, and is rare in men except those with severe metabolic disease or profound estrogen deprivation is unlikely to be random. Biology points toward a hormonal explanation.

There are estrogen receptors in the lining of the shoulder joint. Estrogen suppresses fibroblasts that drive capsular thickening and stiffness, which are the defining features of frozen shoulder. Women treated with aromatase inhibitors or tamoxifen, both of which reduce estrogen activity, experience frozen shoulder at much higher rates. In several cultures, frozen shoulder is colloquially referred to as “50 year shoulder,” reflecting an understanding of its timing that Western medicine has largely overlooked.

Dr. Wittstein’s research suggests that women using systemic estradiol had roughly half the risk of developing frozen shoulder compared to non users. Early recognition and early treatment can dramatically alter the course of the condition. Despite this, many women are told to wait it out for one to two years, enduring prolonged pain, stiffness, sleep disruption, and functional loss. This delay represents unnecessary suffering rooted in outdated assumptions.

Bone Health Is About Fractures, Not Just Bone Density

Bone density scans are important tools, but they are not the whole story. Long term exercise studies such as the EFOPS trial followed women for more than a decade and revealed a critical insight. Women who engaged in sustained strength and impact training reduced their fracture risk by approximately 50 percent, even when gains in bone density plateaued.

This finding underscores a crucial point. Fractures are not caused solely by fragile bones. They are the result of falls, impaired balance, reduced strength, slower reaction time, diminished coordination, loss of muscle power, and decreased confidence in movement.

Exercise improves all of these factors and, even modest improvements matter. A one percent increase in bone density is clinically meaningful. A three percent increase is considered substantial. When these gains are paired with better balance and strength, their protective effect compounds over time.

Waiting for osteoporosis to develop before acting often means missing the window when prevention is most effective.

Estrogen Is Foundational, but It Is Not Enough on Its Own

Menopausal hormone therapy that includes estradiol is approved for the prevention of osteoporosis. It reduces fracture risk and helps preserve bone architecture. This is well established science.

However, estrogen alone cannot fully protect musculoskeletal health. Bones and joints require mechanical loading through resistance and impact exercise. Muscles require adequate protein. Bone remodeling depends on sufficient calcium, vitamins D and K, magnesium, and an overall anti inflammatory dietary pattern.

Exercise often delivers faster functional benefits than medication alone. In some studies, eight months of progressive strength training produced bone improvements comparable to those achieved through years of pharmacologic treatment.

The most powerful strategy is integration. Hormones, movement, nutrition, and balance training work best together. These approaches are not competing solutions. They amplify one another and address the musculoskeletal system as a whole.

Siloed Medicine Is Failing Women in Midlife

Orthopedic surgeons focus on joints. Gynecologists focus on ovaries. Endocrinologists focus on hormones. Too often, no one is responsible for the integrated whole.

This fragmentation helps explain why menopause related musculoskeletal syndromes went unnamed for decades. It explains why frozen shoulder was dismissed, why joint pain was minimized, and why fractures are frequently addressed only after they occur.

When orthopedic surgeons ask about menopausal symptoms and gynecologists ask about shoulder pain, grip strength, and mobility, women are diagnosed earlier. When clinicians collaborate across disciplines, outcomes improve.

Women are not isolated body parts. They are integrated biological systems, and medical care must reflect that reality.

The Bottom Line: Women Deserve Better

Women are not fragile. They are underinformed and largely undersupported.

Midlife musculoskeletal decline is not inevitable, random, or something women should silently endure. The science is finally aligning with what women have been reporting for years. Their pain is real and the timing of their symptoms is meaningful. 

For those who feel seen by this information, thel unPAUSED episodes offer deeper insight and practical guidance. For anyone experiencing joint pain, frozen shoulder, or rapid changes in strength and mobility, the message is clear. Do not wait. Ask better questions. Seek informed care. Advocate for your whole body.

This is not about aging gracefully. It is about aging with strength, function, and dignity. Understanding what is happening inside the body is the first step toward protecting it.

Listen to this two part conversation here or watch here.

This article contains affiliate links.